Implant Sciences to Present at the National Investment Banking Association Capital Conference.WAKEFIELD, Mass. -- Implant Sciences Corporation (AMEX AMEX See: American Stock Exchange : "IMX IMX In My eXperience IMX Interactive Music Exchange (TV show) IMX Integrated Multimedia Exchange IMX Industrywide Mortgage Exchange IMX Intermodal Marketing Extension IMX Inverse Multiplexor ", "IMX.WS") a developer and manufacturer of products for national security, medicine and industry, today announced that the Company will be making a corporate presentation at the National Investment Banking Association's ("NIBA NIBA National Insurance Brokers Association (Australia; established 1982) NIBA National Industrial Belting Association NIBA Northwest Indian Bar Association NIBA National Investment Bankers Association NIBA National Indian Business Association, Inc. ") Capital Conference at the Sheraton New Orleans Sheraton New Orleans, located at 500 Canal Street in the Central Business District of New Orleans, Louisiana, is a 48-story, 479 feet (146 m)-tall skyscraper. Hotel from December 2-3, 2004. Dr. Anthony J. Armini, PhD., CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Implant Sciences, commented, "Over the past several weeks we have made certain important announcements related to the acquisition of Core Systems, the delivery of our Quantum Sniffer(TM) ("QS(TM)") explosives detection devices to the Navy and Army, the procurement of additional orders for the QS(TM) for delivery to the Pakistan Airport Security Force, and the filing of a 510K application with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. proposing a new radioactive source for the treatment of breast cancer. The NIBA Conference will provide us an opportunity to update the investment community on the Company's recent activities. We believe this conference will be the first of several presentations to be made by the Company over the next several months to bring the Implant Sciences' story to the 'street'." About Implant Sciences Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for national security, medicine, and industry. Under development are portable and bench-top trace element detection devices to identify explosives, narcotics narcotics n. 1) techinically, drugs which dull the senses. 2) a popular generic term for drugs which cannot be legally possessed, sold, or transported except for medicinal uses for which a physician or dentist's prescription is required. and other toxic materials. The Company has also received government grants from the US Army, Navy and Air Force, and the Transportation Security Administration to adapt the Company's explosive detection technology to a wide number of security requirements. Using its proprietary ion implantation and thin film coating technologies, Implant Sciences has a sophisticated production line that modifies the surface characteristics of orthopedic joint implants to reduce polyethylene wear, thereby substantially increasing the life of the implants. The Company also manufactures and markets radioactive and non-radioactive products for medical use, including radioactive seeds for treating prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. that are distributed throughout the United States by its own direct sales force. In parallel with the production of these seeds, it is also developing additional brachytherapy products for the treatment of breast, eye, and other cancers. This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect," "should," or similar expressions. These statements are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion